- Home
- INDP vs PALI Comparison
INDP vs PALI Comparison
Compare INDP & PALI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INDP
- PALI
- Stock Information
- Founded
- INDP 2000
- PALI 1996
- Country
- INDP United States
- PALI United States
- Employees
- INDP N/A
- PALI N/A
- Industry
- INDP Biotechnology: Pharmaceutical Preparations
- PALI Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- INDP Health Care
- PALI Health Care
- Exchange
- INDP Nasdaq
- PALI Nasdaq
- Market Cap
- INDP 6.0M
- PALI 5.9M
- IPO Year
- INDP N/A
- PALI N/A
- Fundamental
- Price
- INDP $3.62
- PALI $1.74
- Analyst Decision
- INDP Strong Buy
- PALI Strong Buy
- Analyst Count
- INDP 2
- PALI 2
- Target Price
- INDP $238.00
- PALI $12.00
- AVG Volume (30 Days)
- INDP 1.4M
- PALI 14.9M
- Earning Date
- INDP 11-11-2025
- PALI 11-11-2025
- Dividend Yield
- INDP N/A
- PALI N/A
- EPS Growth
- INDP N/A
- PALI N/A
- EPS
- INDP N/A
- PALI N/A
- Revenue
- INDP N/A
- PALI N/A
- Revenue This Year
- INDP N/A
- PALI N/A
- Revenue Next Year
- INDP N/A
- PALI N/A
- P/E Ratio
- INDP N/A
- PALI N/A
- Revenue Growth
- INDP N/A
- PALI N/A
- 52 Week Low
- INDP $2.22
- PALI $0.53
- 52 Week High
- INDP $58.24
- PALI $4.32
- Technical
- Relative Strength Index (RSI)
- INDP 45.47
- PALI 72.62
- Support Level
- INDP $2.86
- PALI $0.58
- Resistance Level
- INDP $4.50
- PALI $2.28
- Average True Range (ATR)
- INDP 0.99
- PALI 0.23
- MACD
- INDP 0.25
- PALI 0.13
- Stochastic Oscillator
- INDP 19.01
- PALI 66.32
About INDP Indaptus Therapeutics Inc.
Indaptus Therapeutics Inc is a pre-clinical biotechnology company engaged in developing a novel and patented systemically-administered anti-cancer and anti-viral immunotherapy. It has developed a proprietary platform that exploits bacteria's natural ability to activate both innate and adaptive cellular immune pathways. The company's clinical candidate Decoy20, has the ability to elicit single-agent activity and durable anti-tumor responses in the combination setting against colorectal, hepatocellular, pancreatic carcinoma, and non-Hodgkin's lymphoma models.
About PALI Palisade Bio Inc.
Palisade Bio Inc is a clinical-stage biopharma company focused on identifying and developing therapeutics that protect the integrity of the intestinal barrier. Its portfolio consists of a PALI-2108 for the treatment of IBD, including UC and CD, and is researching PALI-1908.